Skip to main content
SpringerLink
Log in

Reception of Sex Steroid Hormones in Thyroid Papillary Cancer Tissue and Relationship with Expression and Content of Transcription Factors Brn-3α and TRIM16

  • ONCOLOGY
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We studied reception of sex steroid hormones in the tissues of thyroid papillary cancer and benign tumor. Enhanced expression of AR and ERβ mRNA reflected malignant tumor growth. Nuclear factors Brn-3α and TRIM16 modulating expression of steroid hormones play an important role in the development of thyroid tumors. It was found that the level of TRIM16 mRNA is associated with the expression of ERβ, which seems to be mediated by its antiestrogen effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kaprin AD, Starinskii VV, Petrova GV. Malignant Neoplasms in Russia in 2015 (Morbidity and Mortality). Moscow, 2017. Russian.

  2. Spirina LV, Gorbunov AK, Kondakova IV, Slonimskaya EM, Usynin EA. Transcription factor BRN-3Α and prostate cancer, relation with hormone receptors and AKT/M-TOR signaling pathway activation. Sib. Onkol. Zh. 2018;(1):26-31. Russian.

    Article  Google Scholar 

  3. Berwick DC, Diss JK, Budhram-Mahadeo VS, Latchman DS. A simple technique for the prediction of interacting proteins reveals a direct Brn-3a-androgen receptor interaction. J. Biol. Chem. 2010;285(20):15,286-15,295.

    Article  CAS  Google Scholar 

  4. Budhram-Mahadeo V, Fujita R, Bitsi S, Sicard P, Heads R. Co-expression of POU4F2/Brn-3b with p53 may be important for controlling expression of pro-apoptotic genes in cardiomyocytes following ischaemic/hypoxic insults. Cell Death Dis. 2014;5:e1503. doi: https://doi.org/10.1038/cddis.2014.452.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Cheung BB, Bell J, Raif A, Bohlken A, Yan J, Roediger B, Poljak A, Smith S, Lee M, Thomas WD, Kavallaris M, Norris M, Haber M, Liu HL, Zajchowski D, Marshall GM. The estrogen-responsive B box protein is a novel regulator of the retinoid signal. J. Biol. Chem. 2006;281(26):18 246-18 256.

  6. Halon A, Nowak-Markwitz E, Maciejczyk A, Pudelko M, Gansukh T, Györffy B, Donizy P, Murawa D, Matkowski R, Spaczynski M, Lage H, Surowiak P. Loss of estrogen receptor beta expression correlates with shorter overall survival and lack of clinical response to chemotherapy in ovarian cancer patients. Anticancer Res. 2011;31(2):711-718.

    CAS  PubMed  Google Scholar 

  7. Magri F, Capelli V, Rotondi M, Leporati P, La Manna L, Ruggiero R, Malovini A, Bellazzi R, Villani L, Chiovato L. Expression of estrogen and androgen receptors in differentiated thyroid cancer: an additional criterion to assess the patient’s risk. Endocr. Relat. Cancer. 2012;19(4):463-471.

    Article  CAS  Google Scholar 

  8. Raif A, Marshall GM, Bell JL, Koach J, Tan O, D’andreti C, Thomas W, Sekyere E, Norris M, Haber M, Kavallaris M, Cheung BB. The estrogen-responsive B box protein (EBBP) restores retinoid sensitivity in retinoid-resistant cancer cells via effects on histone acetylation. Cancer Lett. 2009;277(1):82-90.

    Article  CAS  Google Scholar 

  9. Rubio GA, Catanuto P, Glassberg MK, Lew JI, Elliot SJ. Estrogen receptor subtype expression and regulation is altered in papillary thyroid cancer after menopause. Surgery. 2018;163(1):143-149.

    Article  Google Scholar 

  10. Spirina LV, Kondakova IV, Tarasenko NV, Slonimskaya EM, Usynin EA, Gorbunov AK, Yurmazov ZA, Chigevskaya SY. Targeting of the AKT/m-TOR pathway: biomarkers of resistance to cancer therapy — AKT/m-TOR pathway and resistance to cancer therapy. Zhongguo Fei Ai Za Zhi. 2018;21(1):63-66.

    PubMed  PubMed Central  Google Scholar 

  11. Stanley JA, Aruldhas MM, Chandrasekaran M, Neelamohan R, Suthagar E, Annapoorna K, Sharmila S, Jayakumar J, Jayaraman G, Srinivasan N, Banu SK. Androgen receptor expression in human thyroid cancer tissues: a potential mechanism underlying the gender bias in the incidence of thyroid cancers. J. Steroid Biochem. Mol. Biol. 2012;130(1-2):105-124.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Russian Academy of Sciences, Tomsk, Russia

    L. V. Spirina, S. Yu. Chizhevskaya, I. V. Kondakova & E. L. Choinzonov

  2. Siberian State Medical University, Tomsk, Russia

    L. V. Spirina & E. L. Choinzonov

Authors
  1. L. V. Spirina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Yu. Chizhevskaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. V. Kondakova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. L. Choinzonov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. V. Spirina.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 166, No. 8, pp. 195-199, August, 2018

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Spirina, L.V., Chizhevskaya, S.Y., Kondakova, I.V. et al. Reception of Sex Steroid Hormones in Thyroid Papillary Cancer Tissue and Relationship with Expression and Content of Transcription Factors Brn-3α and TRIM16. Bull Exp Biol Med 166, 237–240 (2018). https://doi.org/10.1007/s10517-018-4322-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-018-4322-4

Key Words

Search

Navigation